However, the result faded after 3 months, which made the researchers debate whether the impact could be from the initial frequent provider visits, motivated lifestyle choices, or the excessive nausea and malaise experienced on initiation of GLP-1 receptor agonists, which could have reduced the alcohol intake during the first few months
It was a miracle drug
For patients who need accountability, behavioral support, and lifestyle coaching, the lack of proactive outreach can be a significant gap
doi: 10.1684/ejd.2019.3691
(Answer: No Molina Medicaid explicitly excludes GLP-1s for obesity in most states
Patients in the United States are suing Eli Lilly because they say they were not told that Mounjaro increases the risks of gastroparesis, sudden vision loss, pancreatitis, and other serious medical conditions